Unknown

Dataset Information

0

Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.


ABSTRACT:

Background

Human angiotensin-converting enzyme 2 (hACE2) is the receptor mediating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. hACE2 expression is low in the lungs and is upregulated after SARS-CoV-2 infection. How such a hACE2-limited pulmonary environment supports efficient virus transmission and how dynamic hACE2 expression affects SARS-CoV-2 infection are unclear.

Methods

We generated stable cell lines with different expression levels of hACE2 to evaluate how the hACE2 expression level can affect SARS-CoV-2 transmission.

Results

We demonstrated that the hACE2 expression level controls the mode of SARS-CoV-2 transmission. The hACE2-limited cells have an advantage for SARS-CoV-2 shedding, which leads to cell-free transmission. By contrast, enhanced hACE2 expression facilitates the SARS-CoV-2 cell-to-cell transmission. Furthermore, this cell-to-cell transmission is likely facilitated by hACE2-containing vesicles, which accommodate numerous SARS-CoV-2 virions and transport them to neighboring cells through intercellular extensions.

Conclusions

This hACE2-mediated switch between cell-free and cell-to-cell transmission routes provides SARS-CoV-2 with advantages for either viral spread or evasion of humoral immunity, thereby contributing to the COVID-19 pandemic and pathogenesis.

SUBMITTER: Yang CF 

PROVIDER: S-EPMC10571257 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.

Yang Chao-Fu CF   Liao Chun-Che CC   Hsu Hung-Wei HW   Liang Jian-Jong JJ   Chang Chih-Shin CS   Ko Hui-Ying HY   Chang Rue-Hsin RH   Tang Wei-Chun WC   Chang Ming-Hao MH   Wang I-Hsuan IH   Lin Yi-Ling YL  

Journal of biomedical science 20231012 1


<h4>Background</h4>Human angiotensin-converting enzyme 2 (hACE2) is the receptor mediating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. hACE2 expression is low in the lungs and is upregulated after SARS-CoV-2 infection. How such a hACE2-limited pulmonary environment supports efficient virus transmission and how dynamic hACE2 expression affects SARS-CoV-2 infection are unclear.<h4>Methods</h4>We generated stable cell lines with different expression levels of hACE2 to ev  ...[more]

Similar Datasets

| S-BSST649 | biostudies-other
| S-EPMC7106554 | biostudies-literature
| S-EPMC7654750 | biostudies-literature
| S-SCDT-EMM-2022-15904 | biostudies-other
| EMPIAR-11176 | biostudies-other
| S-EPMC8346780 | biostudies-literature
| S-EPMC7772801 | biostudies-literature
| S-EPMC7886630 | biostudies-literature
| EMPIAR-11181 | biostudies-other
| S-EPMC7763092 | biostudies-literature